16.53
1.47%
+0.24
After Hours:
16.23
-0.30
-1.81%
Indivior Plc stock is currently priced at $16.53, with a 24-hour trading volume of 48,996.
It has seen a +1.47% increased in the last 24 hours and a -5.70% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $16.33 pivot point. If it approaches the $16.56 resistance level, significant changes may occur.
Previous Close:
$16.29
Open:
$16.35
24h Volume:
48,996
Market Cap:
$2.22B
Revenue:
$1.12B
Net Income/Loss:
$5.00M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
$-383.00M
1W Performance:
+1.10%
1M Performance:
-5.70%
6M Performance:
+0.85%
1Y Performance:
+0.00%
Indivior Plc Stock (INDV) Company Profile
Indivior Plc Stock (INDV) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-13-23 | Initiated | Northland Capital | Outperform |
Indivior Plc Stock (INDV) Latest News
Chilton Investment Co. Inc. Takes Position in Indivior PLC (NASDAQ:INDV) - Defense World
Defense World
Campbell & CO Investment Adviser LLC Purchases 1037 Shares of Indivior PLC (NASDAQ:INDV) - Defense World
Defense World
Indivior (NASDAQ:INDV) Sees Large Volume Increase - Defense World
Defense World
Indivior PLC (NASDAQ:INDV) Stock Holdings Lifted by Royal London Asset Management Ltd. - Defense World
Defense World
Indivior (NASDAQ:INDV) Shares Gap Down to $17.81 - Defense World
Defense World
Indivior (NASDAQ:INDV) Sees Unusually-High Trading Volume - MarketBeat
MarketBeat
Indivior Plc Stock (INDV) Financials Data
Indivior Plc (INDV) Revenue 2024
INDV reported a revenue (TTM) of $1.12 billion for the quarter ending March 31, 2024, a +18.57% rise year-over-year.
Indivior Plc (INDV) Net Income 2024
INDV net income (TTM) was $5.00 million for the quarter ending March 31, 2024, a +110.00% increase year-over-year.
Indivior Plc (INDV) Cash Flow 2024
INDV recorded a free cash flow (TTM) of -$383.00 million for the quarter ending March 31, 2024, a -1,765% decrease year-over-year.
Indivior Plc (INDV) Earnings per Share 2024
INDV earnings per share (TTM) was $0.01 for the quarter ending March 31, 2024, a +102.38% growth year-over-year.
About Indivior Plc
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Cap:
|
Volume (24h):